Longitudinal analysis of Bone Mineral Density (BMD) in HIV-infected patients treated with HAART: Changes in BMD correlate with change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase BMD

D. Nolan; R. Upton; I. James; E. McKinnon; M. John; S. Mallal

Back

Conference presentation

Longitudinal analysis of Bone Mineral Density (BMD) in HIV-infected patients treated with HAART: Changes in BMD correlate with change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase BMD

D. Nolan, R. Upton, I. James, E. McKinnon, M. John and S. Mallal

2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto, Canada, 13/09/2000–15/09/2000)

2000

Abstract

- A cross sectional analysis, a relatively high rate of osteopenia and osteoporosis (49%), which was higher in patients on PI-containing regimens. - Rate of bone loss and observed a paradoxical increase in the BMD in patients treated with indinavir vs. patients treated with nelfinavir and related these changes to the changes in subcutaneous fat, regardless of therapy.

Details

Title: Longitudinal analysis of Bone Mineral Density (BMD) in HIV-infected patients treated with HAART: Changes in BMD correlate with change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase BMD
Authors/Creators: D. Nolan (Author/Creator)
R. Upton (Author/Creator)
I. James (Author/Creator)
E. McKinnon (Author/Creator)
M. John (Author/Creator)
S. Mallal (Author/Creator)
Conference: 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto, Canada, 13/09/2000–15/09/2000)
Identifiers: 991005545067207891
Murdoch Affiliation: Centre for Clinical Immunology and Biomedical Statistics
Language: English
Resource Type: Conference presentation

Metrics

20 Record Views